TGF-β1 protects against Aβ-neurotoxicity via the phosphatidylinositol-3-kinase pathway

Neurobiology of Disease

Volumn 30, Issue 2, 2008, Pages 234-242

  Caraci, Filippo ^a   Battaglia, Giuseppe ^b   Busceti, Carla ^b   Biagioni, Francesca ^b   Mastroiacovo, Federica ^b   Bosco, Paolo ^c   Drago, Filippo ^a   Nicoletti, Ferdinando ^b,d   Sortino, Maria Angela ^a   Copani, Agata ^a,e  

^a UNIVERSITY OF CATANIA   (Italy)

^b IRCCS NEUROMED   (Italy)

^c OASI RESEARCH INSTITUTE IRCCS   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e CNR   (Italy)

Author keywords

catenin; Amyloid; Cell cycle; Hippocampus; Neuronal death; Neurons; PI 3 K; SB431542; Tau; TGF 1

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; AMYLOID BETA PROTEIN; BETA CATENIN; LY 294402; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; TAU PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL ACTIVATION; CELL CYCLE; CONTROLLED STUDY; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RAT; RODENT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMYLOID BETA-PROTEIN; ANIMALS; CELLS, CULTURED; CHROMONES; MALE; MORPHOLINES; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 43049116103     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2008.01.007     Document Type: Article

References (58)

1. Brazil D.P., and Hemmings B.A. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci. 26 (2001) 657-664
2. Brinton R.D. Impact of estrogen therapy on Alzheimer's disease: a fork in the road?. CNS Drugs 18 (2004) 405-422
3. Brionne T.C., Tesseur I., Masliah E., and Wyss Coray T. Loss of TGF-β1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron 40 (2003) 1133-1145
4. Bruno V., Battaglia G., Casabona G., Copani A., Caciagli F., and Nicoletti F. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta. J. Neurosci. 18 (1998) 9594-9600
5. Butterfield D.A., Reed T., Newman S.F., and Sultana R. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic. Biol. Med. 43 (2007) 658-677
6. Caricasole A., Copani A., Caraci F., Aronica E., Rozemuller A.J., Caruso A., Storto M., Gaviraghi G., Terstappen G.C., and Nicoletti F. Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain. J. Neurosci. 24 (2004) 6021-6027
7. Castren E., and Tanila H. Neurotrophins and dementia-keeping in touch. Neuron 51 (2006) 1-3
8. Chalmers K.A., and Love S. Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons. J. Neuropathol. Exp. Neurol. 66 (2007) 158-167
9. Connor B., and Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res. Brain Res. Rev. 27 (1998) 1-39
10. Copani A., Bruno V., Battaglia G., Lenza G., Pellitteri R., Russo A., Stanzani S., and Nicoletti F. Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide. Mol. Pharmacol. 47 (1995) 890-897
11. Copani A., Condorelli F., Caruso A., Vancheri C., Sala A., Giuffrida Stella A.M., Canonico P.L., Nicoletti F., and Sortino M.A. Mitotic signaling by beta-amyloid causes neuronal death. FASEB J. 13 (1999) 2225-2234
12. Copani A., Sortino M.A., Caricasole A., Chiechio S., Chisari M., Battaglia G., Giuffrida-Stella A.M., Vancheri C., and Nicoletti F. Erratic expression of DNA polymerases by beta-amyloid causes neuronal death. FASEB J. 16 (2002) 2006-2008
13. Copani A., Hoozemans J.J., Caraci F., Calafiore M., Van Haaster E.S., Veerhius R., Rozemuller A.J.M., Aronica E., Sortino M.A., and Nicoletti F. DNA polymerase-β is early expressed in neurons of Alzheimer's Disease brain and is loaded into DNA replication forks in neurons challenged with β-amyloid. J. Neurosci. 26 (2006) 10949-10957
14. Demuro A., Mina E., Kayed R., Milton S.C., Parker I., and Glabe C.G. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 280 (2005) 17294-17300
15. Derynck R., and Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425 (2003) 577-584
16. Fuentealba R.A., Farias G., Scheu J., Bronfman M., Marzolo M.P., and Inestrosa N.C. Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease. Brain Res. Brain Res. Rev. 47 (2004) 275-289
17. Gaertner R.F., Wyss-Coray T., Von Euw D., Lesne S., Vivien D., and Lacombe P. Reduced brain tissue perfusion in TGF-beta 1 transgenic mice showing Alzheimer's disease-like cerebrovascular abnormalities. Neurobiol. Dis. 19 (2005) 38-46
18. Garcia Z., Kumar A., Marques M., Cortes I., and Carrera A.C. Phosphoinositide 3-kinase controls early and late events in mammalian cell division. EMBO J. 25 (2006) 655-661
19. Giovanni A., Wirtz-Brugger F., Keramaris E., Slack R., and Park D.S. Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F-DP, in β-amyloid-induced neuronal death. J. Biol. Chem. 274 (1999) 19011-19016
20. Giuffrida M.L., Grasso G., Ruvo M., Pedone C., Saporito A., Marasco D., Pignataro B., Cascio C., Copani A., and Rizzarelli E. Abeta(25-35) and its C- and/or N-blocked derivatives: copper driven structural features and neurotoxicity. J. Neurosc. Res. 85 (2007) 623-633
21. Grammas P., and Ovase R. Cerebrovascular transforming growth factor-β contributes to inflammation in the Alzheimer's disease brain. Am. J. Pathol. 160 (2002) 1583-1587
22. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
23. Harris-White M.E., Chu T., Balverde Z., Sigel J.J., Flanders K.C., and Frautschy S.A. Effects of transforming growth factor-beta (isoforms 1-3) on amyloid-beta deposition, inflammation, and cell targeting in organotypic hippocampal slice cultures. J. Neurosci. 18 (1998) 10366-10374
24. Herrup K., Neve R., Ackerman S.L., and Copani A. Divide and die: cell cycle events as triggers of nerve cell death. J. Neurosci. 24 (2004) 9232-9239
25. Hock Jr. B.J., and Lamb B.T. Transgenic mouse models of Alzheimer's disease. Trends Genet. 17 (2001) S7-S12
26. Hynd M.R., Scott H.L., and Dodd P.R. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem. Int. 45 (2004) 583-595
27. Inman G.J., Nicolas F.J., Callahan J.F., Harling J.D., Gaster L.M., Reith A.D., Laping N.J., and Hill C.S. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62 (2002) 65-74
28. Kihara T., Shimohama S., Sawada H., Honda K., Nakamizo T., Shibasaki H., Kume T., and Akaike A. alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity. J. Biol. Chem. 276 (2001) 13541-13546
29. Kim E.S., Kim R.S., Ren R.F., Hawver D.B., and Flanders K.C. Transforming growth factor-beta inhibits apoptosis induced by beta-amyloid peptide fragment 25-35 in cultured neuronal cells. Brain Res. Mol. Brain Res. 62 (1998) 122-130
30. Lai Y.L., Smith P.M., Lamm W.J.E., and Hildebrandt J. Sampling and analysis of cerebrospinal fluid for chronic studies in awake rats. J. Appl. Physiol. 54 (1983) 1754-1757
31. Lee H.G., Ueda M., Zhu X., Perry G., and Smith M.A. Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway?. J. Neurosci. Res. 84 (2006) 1856-1861
32. Luterman J.D., Haroutunian V., Yemul S., Ho L., Purohit D., Aisen P.S., Mohs R., and Pasinetti G.M. Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. Arch. Neurol. 57 (2000) 1153-1160
33. Makwana M., Jones L.L., Cuthill D., Heike Heuer H., Bohatschek M., Hristova M., Friedrichsen S., Ormsby I., Bueringer D., Koppius A., Bauer K., Doetschman T., and Raivich G. Endogenous transforming growth factor β1 suppresses inflammation and promotes survival in adult CNS. J. Neurosci. 27 (2007) 11201-11213
34. Malin D.H., Crothers M.K., Lake J.R., Goyarzu P., Plotner R.E., Garcia S.A., Spell S.H., Tomsic B.J., Giordano T., and Kowall N.W. Hippocampal injections of amyloid beta-peptide 1-40 impair subsequent one-trial/day reward learning. Neurobiol. Learn. Mem. 76 (2001) 125-137
35. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R.E. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12 (1992) 376-389
36. Miguel-Hidalgo J.J., and Cacabelos R. Beta-amyloid(1-40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield. Acta Neuropathol. (Berl) 95 (1998) 455-465
37. Morimoto K., Yoshimi K., Tonohiro T., Yamada N., Oda T., and Kaneko I. Co-injection of beta-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons. Neuroscience 84 (1998) 479-487
38. Murase S., Mosser E., and Schuman E.M. Depolarization drives beta-catenin into neuronal spines promoting changes in synaptic structure and function. Neuron. 35 (2002) 91-105
39. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., and Cotman C.W. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13 (1993) 1676-1687
40. Prehn J.H., Bindokas V.P., Jordan J., Galindo M.F., Ghadge G.D., Roos R.P., Boise L.H., Thompson C.B., Krajewski S., Reed J.C., and Miller R.J. Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons. Mol. Pharmacol. 49 (1996) 319-328
41. Ren R.F., and Flanders K.C. Transforming growth factors-beta protect primary rat hippocampal neuronal cultures from degeneration induced by beta-amyloid peptide. Brain Res. 732 (1996) 16-24
42. Ren R.F., Hawver D.B., Kim R.S., and Flanders K.C. Transforming growth factor-beta protects human hNT cells from degeneration induced by beta-amyloid peptide: involvement of the TGF-beta type II receptor. Brain Res. Mol. Brain Res. 48 (1997) 315-322
43. Rossig L., Badorff C., Holzmann Y., Zeiher A.M., and Dimmeler S. Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21 Cip1 degradation. J. Biol. Chem. 277 (2002) 9684-9689
44. Shapiro G.I. Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol. Clin. Cancer Res. 10 (2004) 4270-4275
45. Shaw M., Cohen P., and Alessi D.R. Further evidence that the inhibition of glycogen synthase kinase-3beta by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216. FEBS Lett. 416 (1997) 307-311
46. Sortino M.A., Chisari M., Merlo S., Vancheri C., Caruso M., Nicoletti F., Canonico P.L., and Copani A. Glia mediates the neuroprotective action of estradiol on beta-amyloid-induced neuronal death. Endocrinology 145 (2004) 5080-5086
47. Swanson C.J., Bures M., Johnson M.P., Linden A.M., Monn J.A., and Schoepp D.D. Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat. Rev., Drug Discov. 4 (2005) 131-144
48. Takashima A., Honda T., Yasutake K., Michel G., Murayama O., Murayama M., Ishiguro K., and Yamaguchi H. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Neurosci Res. 31 (1998) 317-323
49. Takashima A., Murayama M., Murayama O., Kohno T., Honda T., Yasutake K., Nihonmatsu N., Mercken M., Yamaguchi H., Sugihara S., and Wolozin B. Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9637-9641
50. Ten Dijke P., and Hill C.S. New insights into TGF-beta-Smad signalling. Trends Biochem. Sci. 29 (2004) 265-273
51. Tesseur I., Zou K., Esposito L., Bard F., Berber E., Can J.V., Lin A.H., Crews L., Tremblay P., Mathews P., Mucke L., Masliah E., and Wyss-Coray T. Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology. J. Clin. Invest. 116 (2006) 3060-3069
52. Ueberham U., Ueberham E., Gruschka H., and Arendt T. Altered subcellular location of phosphorylated Smads in Alzheimer's disease. Eur. J. Neurosci. 24 (2006) 2327-2334
53. Wyss-Coray T. Tgf-Beta pathway as a potential target in neurodegeneration and Alzheimer's. Curr. Alzheimer Res. 3 (2006) 191-195
54. Wyss-Coray T., Masliah E., Mallory M., McConlogue L., Johnson-Wood K., Lin C., and Mucke L. Amyloidogenic role of cytokine TGF-β1 in transgenic mice and Alzheimer's disease. Nature 389 (1997) 603-606
55. Yu X., and Malenka R.C. Beta-catenin is critical for dendritic morphogenesis. Nat. Neurosci. 6 (2003) 1169-1177
56. Zhang L., Rubinow D.R., Xaing G., Li B.S., Chang Y.H., Maric D., Barker J.L., and Ma W. Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt. Neuroreport 12 (2001) 1919-1923
57. Zhang H., Zou K., Tesseur I., and Wyss-Coray T. Small molecule tgf-beta mimetics as potential neuroprotective factors. Curr. Alzheimer Res. 2 (2005) 183-186
58. Zhu Y., Culmsee C., Klumpp S., and Krieglstein J. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways. Neuroscience 123 (2004) 897-906